This is a Validated Antibody Database (VAD) review about cat CD14, based on 49 published articles (read how Labome selects the articles), using CD14 antibody in all methods. It is aimed to help Labome visitors find the most suited CD14 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CD14 synonym: monocyte differentiation antigen CD14

Invitrogen
mouse monoclonal (T K4)
  • flow cytometry; human; fig 1a
In order to study the involvement of Notch signaling in NK cell lineage determination, Invitrogen CD14 antibody (Invitrogen, TÜK4) was used in flow cytometry on human samples (fig 1a). J Immunol (2017) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human; loading ...; fig 1a
In order to measure CD80 and CD86 expression on CD14+HLA-DR+ monocytes from patients with Chagas disease, Invitrogen CD14 antibody (Invitrogen, MA 1-82074) was used in flow cytometry on human samples (fig 1a). Rev Soc Bras Med Trop (2016) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human
In order to study the dynamics of Ag-specific CD4(+) T cells during antiretroviral therapy, Invitrogen CD14 antibody (Invitrogen, T??k4) was used in flow cytometry on human samples . J Immunol (2015) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human; 1:800
In order to develop a system to determine human DC development and differentiation, Invitrogen CD14 antibody (Invitrogen, Tuk4) was used in flow cytometry on human samples at 1:800. J Immunol Methods (2015) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human
In order to elucidate regulation of gamma-globin expression in F-cells, Invitrogen CD14 antibody (Life Technologies, TUK4) was used in flow cytometry on human samples . PLoS ONE (2015) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human; fig 1
In order to examine the antibody repertoire of patients with acute systemic lupus erythematosus, Invitrogen CD14 antibody (Invitrogen, TK4) was used in flow cytometry on human samples (fig 1). Nat Immunol (2015) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human
In order to investigate the primary inflammatory and regulatory T cell responses induced by BCG vaccination in adults, Invitrogen CD14 antibody (Invitrogen, clone TuK4) was used in flow cytometry on human samples . Clin Vaccine Immunol (2015) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human
In order to determine if HIV elite controllers have exhausted T cells, Invitrogen CD14 antibody (Invitrogen, TuK4) was used in flow cytometry on human samples . J Infect Dis (2015) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human
In order to test if mesenchymal stromal cells support the growth and survival of leukemic stem cells in vitro, Invitrogen CD14 antibody (Invitrogen, tuk4) was used in flow cytometry on human samples . Stem Cell Res (2015) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human
In order to evaluate immune responses by monocyte isolated from young and old adults before and after influenza vaccination, Invitrogen CD14 antibody (Life Technologies, TuK4) was used in flow cytometry on human samples . J Infect Dis (2015) ncbi
mouse monoclonal (T K4)
  • immunocytochemistry; human
In order to study the role of dendritic cells in relation to T cells, Invitrogen CD14 antibody (Life Technologies, Tuk4) was used in immunocytochemistry on human samples . J Immunol (2014) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human
In order to report the immune responses elicited in an outpatient Phase 2 clinical trial in which subjects were vaccinated with CVD 1208S (DeltaguaBA, Deltaset, Deltasen S. flexneri 2a), Invitrogen CD14 antibody (Caltag, TuK4) was used in flow cytometry on human samples . Front Immunol (2014) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human
In order to examine various DC after flu vaccination, Invitrogen CD14 antibody (Invitrogen, TuK4) was used in flow cytometry on human samples . Immunol Invest (2014) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human
In order to investigate the progression of innate responses to mycobacteria in infants, Invitrogen CD14 antibody (Invitrogen, Tuk4) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human
In order to study NK function in solid tumors, Invitrogen CD14 antibody (Invitrogen, TuK4) was used in flow cytometry on human samples . Int J Cancer (2014) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human
In order to examine the function of NK- and T-cells in order to understand how chronic myeloid leukemia patients maintain the treatment response after IFN-alpha discontinuation, Invitrogen CD14 antibody (Invitrogen, tuk4) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human; fig 1
In order to study mucosal associated invariant T cells and B cell interactions, Invitrogen CD14 antibody (Invitrogen, clone TuK4) was used in flow cytometry on human samples (fig 1). Front Immunol (2014) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human; 1:10; fig 4
In order to investigate the cytotoxicity of acyl glucuronide, Invitrogen CD14 antibody (Invitrogen, TuK4) was used in flow cytometry on human samples at 1:10 (fig 4). Drug Metab Dispos (2014) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human; fig 3
In order to determine the role of conventional and regulatory T cells in protection from HIV-1 infection, Invitrogen CD14 antibody (Invitrogen, TuK4) was used in flow cytometry on human samples (fig 3). AIDS Res Hum Retroviruses (2013) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human; fig 1
In order to measure and characterize T/NK precursors among CD34(+)Lin(-) cell populations circulating in normal human adult peripheral blood, Invitrogen CD14 antibody (Invitrogen, TuK4) was used in flow cytometry on human samples (fig 1). J Immunol (2013) ncbi
mouse monoclonal (T K4)
  • immunocytochemistry; human; fig 1
In order to assess the effect of immunosuppression used for organ transplantation on immune responses to adeno-associated virus capsid antigens, Invitrogen CD14 antibody (Invitrogen, clone TuK4) was used in immunocytochemistry on human samples (fig 1). Hum Gene Ther (2013) ncbi
mouse monoclonal (T K4)
In order to investigate mucosal dysfunction in relation to HIV/SIV pathogenesis, Invitrogen CD14 antibody (Invitrogen, T?uK4) was used . J Immunol (2013) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human
In order to examine the role of IL-17A-producing multifunctional T cells in the pathogenesis of toxic shock syndrome, Invitrogen CD14 antibody (Invitrogen, TuK4) was used in flow cytometry on human samples . Clin Immunol (2013) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human; fig 1
In order to identify integrin alpha2 as a novel stem cell marker, Invitrogen CD14 antibody (Invitrogen, TuK4) was used in flow cytometry on human samples (fig 1). Stem Cells (2013) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human; fig 1
In order to study B cell populations in patients with N-methyl-D-aspartate receptor encephalitis, Invitrogen CD14 antibody (Invitrogen, TUK4) was used in flow cytometry on human samples (fig 1). Dev Med Child Neurol (2013) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human
In order to explore the multifunctional IL-17A responses against S. Typhi antigens in T memory subsets, Invitrogen CD14 antibody (Invitrogen, clone TuK4) was used in flow cytometry on human samples . PLoS ONE (2012) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human; fig 1
In order to study influenza-specific CD4 T cells respond to vaccination using Ki67 as a marker, Invitrogen CD14 antibody (Invitrogen, clone TUK4) was used in flow cytometry on human samples (fig 1). Vaccine (2012) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human; fig 3
In order to discuss how co-infections and secondary parasite infections may disrupt the immunologic responses induced by a pre-existing parasitic infection, Invitrogen CD14 antibody (InVitrogen, TuK4) was used in flow cytometry on human samples (fig 3). PLoS ONE (2012) ncbi
mouse monoclonal (T K4)
  • immunocytochemistry; human
In order to discuss the use of umbilical cord blood as a source of transplantable hematopoietic stem cells, Invitrogen CD14 antibody (Invitrogen, TuK4) was used in immunocytochemistry on human samples . Transfusion (2011) ncbi
mouse monoclonal (T K4)
  • flow cytometry; Rhesus monkey; fig 1
In order to characterize different macaque NK cell subpopulations, Invitrogen CD14 antibody (Invitrogen, TuK4) was used in flow cytometry on Rhesus monkey samples (fig 1). Immunology (2011) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human; fig 2
In order to discuss the live attenuated yellow fever vaccines, Invitrogen CD14 antibody (Caltag, TuK4) was used in flow cytometry on human samples (fig 2). J Infect Dis (2011) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human; fig 2
In order to describe a 15-year-old male with longitudinally extensive transverse myelitis with magnetic resonance imaging findings of oedema, cavitation, and gadolinium enhancement, Invitrogen CD14 antibody (Invitrogen, TUK4) was used in flow cytometry on human samples (fig 2). Dev Med Child Neurol (2011) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human; fig 4
In order to test if anti-CD8 Abs induce effector function, Invitrogen CD14 antibody (Caltag, clone Tuk4) was used in flow cytometry on human samples (fig 4). J Immunol (2011) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human; fig 1
In order to test if rejection of AAV-transduced hepatocytes is due to AAV capsid-specific CD8 positive T cells that become reactivated upon gene transfer, Invitrogen CD14 antibody (Invitrogen, clone TuK4) was used in flow cytometry on human samples (fig 1). Mol Ther (2011) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human; fig 1
In order to examine human cross-reactive T cells against a pandemic virus, Invitrogen CD14 antibody (Invitrogen, clone TUK4) was used in flow cytometry on human samples (fig 1). Vaccine (2011) ncbi
mouse monoclonal (T K4)
  • immunocytochemistry; human
In order to discuss the use of internal antigens to provide better protection against multiple influenza subtypes, Invitrogen CD14 antibody (Invitrogen, TuK4) was used in immunocytochemistry on human samples . Clin Infect Dis (2011) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human; 1:40; fig 3
In order to investigate targeting CEACAM6 for treatment of pancreatic adenocarcinomas, Invitrogen CD14 antibody (CalTag, clone TUK 4) was used in flow cytometry on human samples at 1:40 (fig 3). J Pathol (2009) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human; fig 4
In order to test if leukocyte Ig-like receptor A2 regulates DC differentiation using a leprosy model, Invitrogen CD14 antibody (Caltag, TUK4) was used in flow cytometry on human samples (fig 4). J Immunol (2007) ncbi
mouse monoclonal (T K4)
  • flow cytometry; African green monkey; fig 1
In order to discuss available reagents for studying the neotropical primate squirrel monkey, Invitrogen CD14 antibody (Caltag Laboratories, TuK4) was used in flow cytometry on African green monkey samples (fig 1). J Immunol Methods (2005) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human; fig 2
In order to assess the effects of a TransFix-based stabilization technique on leukocyte scatter characteristics, immunophenotyping, membrane permeability, absolute cell counting and morphology, Invitrogen CD14 antibody (Caltag Laboratories, TUK4) was used in flow cytometry on human samples (fig 2). J Immunol Methods (2004) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human
In order to ask if flow cytometry can be used for the detection of bone marrow involvement in the different types of B-cell malignant neoplasms, Invitrogen CD14 antibody (Zymed, TUK4) was used in flow cytometry on human samples . Cytometry B Clin Cytom (2003) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human; fig 4
In order to report that CD34(+) progenitor cell-derived Langerhans cells-type DCs exhibit a differentiation state-dependent susceptibility to CMV infection, Invitrogen CD14 antibody (Caltag, TUK4) was used in flow cytometry on human samples (fig 4). J Virol (2003) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human
In order to describe a protocol for the isolation HSC from human fetal liver, Invitrogen CD14 antibody (Caltag, T??K4) was used in flow cytometry on human samples . Biol Proced Online (2002) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human
In order to report how to isolate highly purified hematopoietic intermediates, Invitrogen CD14 antibody (Caltag, TUK4) was used in flow cytometry on human samples . Proc Natl Acad Sci U S A (2002) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human
In order to determine of proinflammatory cytokine responses induced by certain bacterial protein adhesins are dependent on TLRs, Invitrogen CD14 antibody (Caltag, Tuk4) was used in flow cytometry on human samples . Clin Diagn Lab Immunol (2002) ncbi
mouse monoclonal (T K4)
  • flow cytometry; Rhesus monkey
In order to examine the innate and adaptive immune responses of rhesus macaques infected with SIVmac251, Invitrogen CD14 antibody (BioSource, Tuk4) was used in flow cytometry on Rhesus monkey samples . J Virol (2000) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human
In order to characterize the cells present in the cutaneous blister fluid patients with toxic epidermal necrolysis, Invitrogen CD14 antibody (Caltag, TuK4) was used in flow cytometry on human samples . Clin Exp Immunol (2000) ncbi
mouse monoclonal (T K4)
  • flow cytometry; human
In order to determine the number of CD4, CCR5, and CXCR4 antibody-binding sites on various T cells and macrophages, Invitrogen CD14 antibody (Caltag, Tuk4) was used in flow cytometry on human samples . Proc Natl Acad Sci U S A (1999) ncbi
mouse monoclonal (T K4)
  • immunocytochemistry; human; fig 2
In order to describe the cellular composition and organization of lymphoid aggregates in the stratum basalis of uterine endometrium, Invitrogen CD14 antibody (Caltag, TUK 4) was used in immunocytochemistry on human samples (fig 2). J Leukoc Biol (1997) ncbi
Articles Reviewed
  1. Kyoizumi S, Kubo Y, Kajimura J, Yoshida K, Hayashi T, Nakachi K, et al. Fate Decision Between Group 3 Innate Lymphoid and Conventional NK Cell Lineages by Notch Signaling in Human Circulating Hematopoietic Progenitors. J Immunol. 2017;199:2777-2793 pubmed publisher
  2. Soares A, Neves P, Cavalcanti M, Marinho S, Oliveira W, Souza J, et al. Expression of co-stimulatory molecules CD80 and CD86 is altered in CD14 + HLA-DR + monocytes from patients with Chagas disease following induction by Trypanosoma cruzi recombinant antigens. Rev Soc Bras Med Trop. 2016;49:632-636 pubmed publisher
  3. Riou C, Tanko R, Soares A, Masson L, Werner L, Garrett N, et al. Restoration of CD4+ Responses to Copathogens in HIV-Infected Individuals on Antiretroviral Therapy Is Dependent on T Cell Memory Phenotype. J Immunol. 2015;195:2273-2281 pubmed publisher
  4. Lee J, Breton G, Aljoufi A, Zhou Y, PUHR S, Nussenzweig M, et al. Clonal analysis of human dendritic cell progenitor using a stromal cell culture. J Immunol Methods. 2015;425:21-6 pubmed publisher
  5. Grieco A, Billett H, Green N, Driscoll M, Bouhassira E. Variation in Gamma-Globin Expression before and after Induction with Hydroxyurea Associated with BCL11A, KLF1 and TAL1. PLoS ONE. 2015;10:e0129431 pubmed publisher
  6. Tipton C, Fucile C, DARCE J, Chida A, Ichikawa T, Gregoretti I, et al. Diversity, cellular origin and autoreactivity of antibody-secreting cell population expansions in acute systemic lupus erythematosus. Nat Immunol. 2015;16:755-65 pubmed publisher
  7. Boer M, Prins C, van Meijgaarden K, van Dissel J, Ottenhoff T, Joosten S. Mycobacterium bovis BCG Vaccination Induces Divergent Proinflammatory or Regulatory T Cell Responses in Adults. Clin Vaccine Immunol. 2015;22:778-88 pubmed publisher
  8. Pombo C, Wherry E, Gostick E, Price D, Betts M. Elevated Expression of CD160 and 2B4 Defines a Cytolytic HIV-Specific CD8+ T-Cell Population in Elite Controllers. J Infect Dis. 2015;212:1376-86 pubmed publisher
  9. Ito S, Barrett A, Dutra A, Pak E, Miner S, Keyvanfar K, et al. Long term maintenance of myeloid leukemic stem cells cultured with unrelated human mesenchymal stromal cells. Stem Cell Res. 2015;14:95-104 pubmed publisher
  10. Mohanty S, Joshi S, Ueda I, Wilson J, Blevins T, Siconolfi B, et al. Prolonged proinflammatory cytokine production in monocytes modulated by interleukin 10 after influenza vaccination in older adults. J Infect Dis. 2015;211:1174-84 pubmed publisher
  11. Yu C, Becker C, Metang P, Marches F, Wang Y, Toshiyuki H, et al. Human CD141+ dendritic cells induce CD4+ T cells to produce type 2 cytokines. J Immunol. 2014;193:4335-43 pubmed publisher
  12. Toapanta F, Simon J, Barry E, Pasetti M, Levine M, Kotloff K, et al. Gut-Homing Conventional Plasmablasts and CD27(-) Plasmablasts Elicited after a Short Time of Exposure to an Oral Live-Attenuated Shigella Vaccine Candidate in Humans. Front Immunol. 2014;5:374 pubmed publisher
  13. Kobie J, Treanor J, Ritchlin C. Transient decrease in human peripheral blood myeloid dendritic cells following influenza vaccination correlates with induction of serum antibody. Immunol Invest. 2014;43:606-15 pubmed publisher
  14. Shey M, Nemes E, Whatney W, de Kock M, Africa H, Barnard C, et al. Maturation of innate responses to mycobacteria over the first nine months of life. J Immunol. 2014;192:4833-43 pubmed publisher
  15. Prinz P, Mendler A, Brech D, Masouris I, Oberneder R, Noessner E. NK-cell dysfunction in human renal carcinoma reveals diacylglycerol kinase as key regulator and target for therapeutic intervention. Int J Cancer. 2014;135:1832-41 pubmed publisher
  16. Ilander M, Kreutzman A, Rohon P, Melo T, Faber E, Porkka K, et al. Enlarged memory T-cell pool and enhanced Th1-type responses in chronic myeloid leukemia patients who have successfully discontinued IFN-? monotherapy. PLoS ONE. 2014;9:e87794 pubmed publisher
  17. Salerno Goncalves R, Rezwan T, Sztein M. B cells modulate mucosal associated invariant T cell immune responses. Front Immunol. 2014;4:511 pubmed publisher
  18. Miyashita T, Kimura K, Fukami T, Nakajima M, Yokoi T. Evaluation and mechanistic analysis of the cytotoxicity of the acyl glucuronide of nonsteroidal anti-inflammatory drugs. Drug Metab Dispos. 2014;42:1-8 pubmed publisher
  19. Pattacini L, Murnane P, Kahle E, Bolton M, Delrow J, Lingappa J, et al. Differential regulatory T cell activity in HIV type 1-exposed seronegative individuals. AIDS Res Hum Retroviruses. 2013;29:1321-9 pubmed publisher
  20. Kyoizumi S, Kubo Y, Kajimura J, Yoshida K, Imai K, Hayashi T, et al. Age-associated changes in the differentiation potentials of human circulating hematopoietic progenitors to T- or NK-lineage cells. J Immunol. 2013;190:6164-72 pubmed publisher
  21. Parzych E, Li H, Yin X, Liu Q, Wu T, Podsakoff G, et al. Effects of immunosuppression on circulating adeno-associated virus capsid-specific T cells in humans. Hum Gene Ther. 2013;24:431-42 pubmed publisher
  22. Canary L, Vinton C, Morcock D, Pierce J, Estes J, Brenchley J, et al. Rate of AIDS progression is associated with gastrointestinal dysfunction in simian immunodeficiency virus-infected pigtail macaques. J Immunol. 2013;190:2959-65 pubmed publisher
  23. McArthur M, Sztein M. Unexpected heterogeneity of multifunctional T cells in response to superantigen stimulation in humans. Clin Immunol. 2013;146:140-52 pubmed publisher
  24. Wong W, Sigvardsson M, Astrand Grundström I, Hogge D, Larsson J, Qian H, et al. Expression of integrin ?2 receptor in human cord blood CD34+CD38-CD90+ stem cells engrafting long-term in NOD/SCID-IL2R?(c) null mice. Stem Cells. 2013;31:360-71 pubmed publisher
  25. Dale R, Pillai S, Brilot F. Cerebrospinal fluid CD19(+) B-cell expansion in N-methyl-D-aspartate receptor encephalitis. Dev Med Child Neurol. 2013;55:191-3 pubmed publisher
  26. McArthur M, Sztein M. Heterogeneity of multifunctional IL-17A producing S. Typhi-specific CD8+ T cells in volunteers following Ty21a typhoid immunization. PLoS ONE. 2012;7:e38408 pubmed publisher
  27. Li X, Miao H, Henn A, Topham D, Wu H, Zand M, et al. Ki-67 expression reveals strong, transient influenza specific CD4 T cell responses after adult vaccination. Vaccine. 2012;30:4581-4 pubmed publisher
  28. Lyke K, Dabo A, Arama C, Daou M, Diarra I, Wang A, et al. Reduced T regulatory cell response during acute Plasmodium falciparum infection in Malian children co-infected with Schistosoma haematobium. PLoS ONE. 2012;7:e31647 pubmed publisher
  29. Barcena A, Muench M, Kapidzic M, Gormley M, Goldfien G, Fisher S. Human placenta and chorion: potential additional sources of hematopoietic stem cells for transplantation. Transfusion. 2011;51 Suppl 4:94S-105S pubmed publisher
  30. Vargas Inchaustegui D, Demberg T, Robert Guroff M. A CD8?(-) subpopulation of macaque circulatory natural killer cells can mediate both antibody-dependent and antibody-independent cytotoxic activities. Immunology. 2011;134:326-40 pubmed publisher
  31. Luiza Silva M, Campi Azevedo A, Batista M, Martins M, Avelar R, da Silveira Lemos D, et al. Cytokine signatures of innate and adaptive immunity in 17DD yellow fever vaccinated children and its association with the level of neutralizing antibody. J Infect Dis. 2011;204:873-83 pubmed publisher
  32. Dale R, Tantsis E, Merheb V, Brilot F. Cerebrospinal fluid B-cell expansion in longitudinally extensive transverse myelitis associated with neuromyelitis optica immunoglobulin G. Dev Med Child Neurol. 2011;53:856-60 pubmed publisher
  33. Clement M, Ladell K, Ekeruche Makinde J, Miles J, Edwards E, Dolton G, et al. Anti-CD8 antibodies can trigger CD8+ T cell effector function in the absence of TCR engagement and improve peptide-MHCI tetramer staining. J Immunol. 2011;187:654-63 pubmed publisher
  34. Li H, Lasaro M, Jia B, Lin S, Haut L, High K, et al. Capsid-specific T-cell responses to natural infections with adeno-associated viruses in humans differ from those of nonhuman primates. Mol Ther. 2011;19:2021-30 pubmed publisher
  35. Scheible K, Zhang G, Baer J, Azadniv M, Lambert K, Pryhuber G, et al. CD8+ T cell immunity to 2009 pandemic and seasonal H1N1 influenza viruses. Vaccine. 2011;29:2159-68 pubmed publisher
  36. Berthoud T, Hamill M, Lillie P, Hwenda L, Collins K, Ewer K, et al. Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1. Clin Infect Dis. 2011;52:1-7 pubmed publisher
  37. Strickland L, Ross J, Williams S, Ross S, Romero M, Spencer S, et al. Preclinical evaluation of carcinoembryonic cell adhesion molecule (CEACAM) 6 as potential therapy target for pancreatic adenocarcinoma. J Pathol. 2009;218:380-90 pubmed publisher
  38. Lee D, Sieling P, Ochoa M, Krutzik S, Guo B, Hernandez M, et al. LILRA2 activation inhibits dendritic cell differentiation and antigen presentation to T cells. J Immunol. 2007;179:8128-36 pubmed
  39. Contamin H, Loizon S, Bourreau E, Michel J, Garraud O, Mercereau Puijalon O, et al. Flow cytometry identification and characterization of mononuclear cell subsets in the neotropical primate Saimiri sciureus (squirrel monkey). J Immunol Methods. 2005;297:61-71 pubmed
  40. Canonico B, Zamai L, Burattini S, Granger V, Mannello F, Gobbi P, et al. Evaluation of leukocyte stabilisation in TransFix-treated blood samples by flow cytometry and transmission electron microscopy. J Immunol Methods. 2004;295:67-78 pubmed
  41. Stacchini A, Demurtas A, Godio L, Martini G, Antinoro V, Palestro G. Flow cytometry in the bone marrow staging of mature B-cell neoplasms. Cytometry B Clin Cytom. 2003;54:10-8 pubmed
  42. Hertel L, Lacaille V, Strobl H, Mellins E, Mocarski E. Susceptibility of immature and mature Langerhans cell-type dendritic cells to infection and immunomodulation by human cytomegalovirus. J Virol. 2003;77:7563-74 pubmed
  43. Muench M, Suskind D, Barcena A. Isolation, growth and identification of colony-forming cells with erythroid, myeloid, dendritic cell and NK-cell potential from human fetal liver. Biol Proced Online. 2002;4:10-23 pubmed
  44. Manz M, Miyamoto T, Akashi K, Weissman I. Prospective isolation of human clonogenic common myeloid progenitors. Proc Natl Acad Sci U S A. 2002;99:11872-7 pubmed
  45. Hajishengallis G, Martin M, Sojar H, Sharma A, Schifferle R, DeNardin E, et al. Dependence of bacterial protein adhesins on toll-like receptors for proinflammatory cytokine induction. Clin Diagn Lab Immunol. 2002;9:403-11 pubmed
  46. Giavedoni L, Velasquillo M, Parodi L, Hubbard G, Hodara V. Cytokine expression, natural killer cell activation, and phenotypic changes in lymphoid cells from rhesus macaques during acute infection with pathogenic simian immunodeficiency virus. J Virol. 2000;74:1648-57 pubmed
  47. Le Cleach L, Delaire S, Boumsell L, Bagot M, Bourgault Villada I, Bensussan A, et al. Blister fluid T lymphocytes during toxic epidermal necrolysis are functional cytotoxic cells which express human natural killer (NK) inhibitory receptors. Clin Exp Immunol. 2000;119:225-30 pubmed
  48. Lee B, Sharron M, Montaner L, Weissman D, Doms R. Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages. Proc Natl Acad Sci U S A. 1999;96:5215-20 pubmed
  49. Yeaman G, Guyre P, Fanger M, Collins J, White H, Rathbun W, et al. Unique CD8+ T cell-rich lymphoid aggregates in human uterine endometrium. J Leukoc Biol. 1997;61:427-35 pubmed